Multiple sclerosis is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances. (continue reading on Wikipedia)

Multiple Sclerosis (MS) and LDN

As a disease involving immune dysfunction, multiple sclerosis can respond well to Low Dose Naltrexone. Multiple sclerosis is one of the most common diseases among LDN patients.

Low Dose Naltrexone at the National Multiple Sclerosis Society